Ubs Oconnor LLC Lava Therapeutics Nv Transaction History

Ubs Oconnor LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$1.59 - $3.97 $80,724 - $201,556	-50,770 Reduced 71.23%	20,502 $34,000
Q4 2022 Feb 14, 2023	SELL	$3.37 - $7.31 $12,563 - $27,251	-3,728 Reduced 4.97%	71,272 $0
Q3 2022 Nov 14, 2022	BUY	$2.34 - $4.75 $175,500 - $356,250	75,000 New	75,000 $343 Million

3.61M

32.9K

500

Ticker LVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,797,700
Market Cap $26.8M
Description
LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer...

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

Stay updated on Ubs Oconnor LLC with notifications on news.